Go Pro
→ The Pentagon is desperate (From Freedom Financial) (Ad)tc pixel Free SVA Stock Alerts

Sernova (SVA) Competitors

Sernova logo
C$0.11 0.00 (0.00%)
As of 09:50 AM Eastern
Compare

SVA vs. HBP, SCYB, COM, NVH, and PDP

Should you buy Sernova stock or one of its competitors? Sernova's main competitors and comparable companies include Helix BioPharma (HBP), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), and Pediapharm (PDP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Sernova compare to Helix BioPharma?

Helix BioPharma (TSE:HBP) and Sernova (TSE:SVA) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

Helix BioPharma is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helix BioPharmaN/AN/A-C$50.55M-C$0.04N/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

Sernova's return on equity of 55.85% beat Helix BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Helix BioPharmaN/A -21.54% -279.98%
Sernova N/A 55.85%-119.26%

Helix BioPharma has a beta of 0.433836, meaning that its share price is 57% less volatile than the broader market. Comparatively, Sernova has a beta of -0.460559, meaning that its share price is 146% less volatile than the broader market.

0.0% of Helix BioPharma shares are held by institutional investors. Comparatively, 0.0% of Sernova shares are held by institutional investors. 2.2% of Helix BioPharma shares are held by company insiders. Comparatively, 12.1% of Sernova shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Helix BioPharma's average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
Helix BioPharma Neutral
Sernova Neutral

Summary

Sernova beats Helix BioPharma on 6 of the 7 factors compared between the two stocks.

How does Sernova compare to Scythian Biosciences?

Sernova (TSE:SVA) and Scythian Biosciences (CVE:SCYB) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

In the previous week, Sernova's average media sentiment score of 0.00 equaled Scythian Biosciences'average media sentiment score.

Company Overall Sentiment
Sernova Neutral
Scythian Biosciences Neutral

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$35.70M-C$0.04N/A
Scythian BiosciencesN/AN/AN/AN/AN/A

Sernova's return on equity of 55.85% beat Scythian Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A 55.85% -119.26%
Scythian Biosciences N/A N/A N/A

Summary

Sernova beats Scythian Biosciences on 3 of the 4 factors compared between the two stocks.

How does Sernova compare to 138267 (COM.TO)?

Sernova (TSE:SVA) and 138267 (COM.TO) (TSE:COM) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

In the previous week, Sernova's average media sentiment score of 0.00 equaled 138267 (COM.TO)'saverage media sentiment score.

Company Overall Sentiment
Sernova Neutral
138267 (COM.TO) Neutral

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$35.70M-C$0.04N/A
138267 (COM.TO)N/AN/AN/AN/AN/A

Sernova's return on equity of 55.85% beat 138267 (COM.TO)'s return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A 55.85% -119.26%
138267 (COM.TO) N/A N/A N/A

Summary

Sernova beats 138267 (COM.TO) on 3 of the 4 factors compared between the two stocks.

How does Sernova compare to Novoheart?

Sernova (TSE:SVA) and Novoheart (CVE:NVH) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Novoheart has higher revenue and earnings than Sernova. Novoheart is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$35.70M-C$0.04N/A
NovoheartC$423.50K236.08-C$7.17M-C$0.04N/A

0.0% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Sernova's average media sentiment score of 0.00 equaled Novoheart'saverage media sentiment score.

Company Overall Sentiment
Sernova Neutral
Novoheart Neutral

Sernova's return on equity of 55.85% beat Novoheart's return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A 55.85% -119.26%
Novoheart N/A N/A N/A

Summary

Sernova and Novoheart tied by winning 4 of the 8 factors compared between the two stocks.

How does Sernova compare to Pediapharm?

Pediapharm (CVE:PDP) and Sernova (TSE:SVA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Pediapharm has higher revenue and earnings than Sernova. Pediapharm is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PediapharmC$11.16M5.95-C$16.15M-C$0.07N/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

In the previous week, Pediapharm's average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
Pediapharm Neutral
Sernova Neutral

Sernova's return on equity of 55.85% beat Pediapharm's return on equity.

Company Net Margins Return on Equity Return on Assets
PediapharmN/A N/A N/A
Sernova N/A 55.85%-119.26%

Summary

Sernova beats Pediapharm on 5 of the 8 factors compared between the two stocks.

Get Sernova News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SVA vs. The Competition

Export
MetricSernovaBiotechnology IndustryHealthcare SectorTSE Exchange
Market CapC$41.54MC$3.73BC$7.00BC$12.59B
Dividend Yield7.86%3.76%2.58%6.20%
P/E Ratio-2.7510.39268.5234.90
Price / SalesN/A1,234.06574.0610.05
Price / Cash6.15102.5472.2682.29
Price / Book-4.0118.2413.314.64
Net Income-C$35.70M-C$13.23MC$3.44BC$299.09M
7 Day PerformanceN/A3.71%1.99%2.05%
1 Month Performance-12.00%-0.73%-0.37%3.40%
1 Year Performance-42.11%60.69%70.61%36.01%

Sernova Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SVA
Sernova
N/AC$0.11
flat		N/A-42.1%C$41.54MN/AN/A1,959
HBP
Helix BioPharma
N/AC$1.58
+2.6%		N/A+53.7%C$120.68MN/AN/A9
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%		N/A+0.0%C$102.38MN/AN/AN/A
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/AN/AN/A
NVH
Novoheart
N/AC$0.53
+1.9%		N/A+0.0%C$99.98MC$423.50KN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:SVA) was last updated on 8/12/2026 by MarketBeat.com Staff.
From Our Partners
7 Bankers Met in Secret (Now We Pay for It)
A little-known meeting in 1910 cost the average American family their entire financial freedom. They met in se...
Decentralized Masters | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The trading strategy that works BECAUSE you have a life
Tim Sykes built a trading strategy for people who can't watch charts from 9:30 to 4:00 every day. It's not ...
Tim Sykes | Sponsoredtc pixel
Could Your Bank Stop AI in Time?
An AI model recently breached a company's systems, and the co-founder warned that defenders now need frontier-...
Priority Gold | Sponsoredtc pixel
The oil crisis is spreading faster than you think
Tanker traffic through Hormuz has plunged from 110-130 daily transits to near zero, while 17% of Qatar's LNG c...
Golden Portfolio | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
SpaceX pays a 10X launch penalty
SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...
Freedom Financial | Sponsoredtc pixel